VistaGen Therapeutics (VTGN) Earnings
|
Expand Research on VTGN
| Next EPS Date | 11/5/26 | EPS Growth Rate | +29.6% |
|---|---|---|---|
| Average EPS % Beat Rate | -5.9% | Revenue Growth Rate | -99.8% |
| Average % Move 1-Wk after EPS | -1.8% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/5/26  |
Q227 | N/A | -$0.38 | N/A | N/A | $500K | N/A | N/A | N/A | ||
| 8/13/26 |
Q127 | N/A | -$0.25 | N/A | N/A | $300K | N/A | N/A | N/A | ||
| 8/12/26 |
Q127 | N/A | -$0.25 | N/A | N/A | $300K | N/A | N/A | N/A | ||
| 8/6/26 |
Q127 | N/A | -$0.25 | N/A | N/A | $300K | N/A | N/A | N/A | ||
| 11/13/25 |
Q226 | -$0.54 | $0.00 | -$0.54 | $258M | N/A | N/A |  | | Details | |
| 8/7/25 |
Q126 | N/A | -$0.61 | N/A | N/A | $400K | N/A | N/A | N/A | ||
| 2/13/24 |
Q324 | -$0.22 | $0.00 | -$0.22 | $410K | N/A | N/A | | | Details | |
| 8/10/23 | Q124 | -$0.94 | -$0.86 | -$0.08 | $170K | $184.6K | N/A | | | Details |
